Status: Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
The purpose of this study is to evaluate the efficacy and safety of KarXT for the treatment of manic episodes in Bipolar-I Disorder
Participants needed: 274
Trial details
Phase: Phase 3Age: 18-65Biological sex: AllType: InterventionalSponsor: Bristol-Myers SquibbUpdated: Jun 26, 2026Locations: 69
Eligibility criteria
Participants must have a primary diagnosis of Bipolar-I disorder established by... [+5]
Participants must not have any primary Diagnostic and Statistical Manual of Ment... [+6]